StockData
Creative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc. (CELZ) income statement

CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$0.40−0.04 (-8.52%)

Close on Nov 20, 2026Market cap $2.65MP/E –Yield –

Creative Medical Technology Holdings, Inc. financial ratios

See a number that looks wrong?